apollo
0
Written By Bayyarapu Mahesh Kumar , M Pharmacy
Reviewed By Santoshini Reddy G , M Pharmacy
Cogni-Plus 250mg Injection 2 ml belongs to the group of psychostimulant class of medicines. It is used in the treatment of Disturbances of consciousness resulting from brain operation, head injuries, and acute stage of cerebral infarction (stroke) in adults. This medication works by preventing the release of free fatty acids and raising the synthesis of phosphatidylcholine and sphingomyelin, which stabilizes the cell membranes. Side effects of this medicine include insomnia (difficulty sleeping), nausea, feeling of warmth, loss of appetite, convulsions, and injection site reactions.
Read more
rxMedicinePrescription drug

Whats That

tooltip

Composition :

CITICOLINE-250MG

Manufacturer/Marketer :

Galaxus Pharmaceuticals

Consume Type :

PARENTERAL

Return Policy :

Not Returnable

Expires on or after :

About Cogni-Plus 250mg Injection 2 ml

Cogni-Plus 250mg Injection 2 ml belongs to a group of medications called 'psychostimulants' used to treat disturbances of consciousness resulting from head injuries, brain operation and acute stage of cerebral infarction (stroke) in adults.

Cogni-Plus 250mg Injection 2 ml contains 'Citicoline', which stabilizes cell membranes by increasing phosphatidylcholine and sphingomyelin synthesis and by inhibiting the release of free fatty acids; thereby, it enhances recovery in patients who had their consciousness disturbed by a head injury or any other brain-related problem and who underwent surgery.

In some cases, Cogni-Plus 250mg Injection 2 ml may cause injection site reactions, rash, insomnia (inability to sleep), nausea, feeling of warmth, anorexia (loss of appetite), convulsions, transient diplopia (double vision) and dyspnea (shortness of breath). If these side effects persist or worsen, consult your doctor immediately. 

Cogni-Plus 250mg Injection 2 ml is not recommended to be used in patients with over-functioning of the sympathetic nervous system or who have a history of hypersensitivity to Citicoline. If you are pregnant or breastfeeding, please inform your doctor so that your doctor will weigh the benefits and any potential risks before prescribing it to you. Cogni-Plus 250mg Injection 2 ml may cause irregular body movement and double vision; thus, avoid operating machinery or driving after taking this medicine. 

Uses of Cogni-Plus 250mg Injection 2 ml

Treatment of Disturbances of consciousness resulting from head injuries, brain operation and acute stage of cerebral infarction (stroke) in adults

Directions for Use

Cogni-Plus 250mg Injection 2 ml will be administered by a qualified healthcare professional. Kindly do not self-administer.

Medicinal Benefits

Cogni-Plus 250mg Injection 2 ml contains 'Citicoline’, a psychostimulant or nootropic drug used to nourish and minimize damage to the nerve cells in various conditions associated with the brain. It increases the activity of the central nervous system (brain and spinal cord) and regenerates nerve cells by promoting the synthesis of phospholipids in the brain. it improves recovery in patients who had their consciousness disturbed by a head injury or any other brain-related problem and who underwent surgery.

How Cogni-Plus 250mg Injection 2 ml Works

Cogni-Plus 250mg Injection 2 ml contains 'Citicoline', which stabilizes cell membranes by increasing phosphatidylcholine and sphingomyelin synthesis and by inhibiting the release of free fatty acids; thereby, it enhances recovery in patients who had their consciousness disturbed by a head injury or any other brain-related problem and who underwent surgery.

Storage

Store in a cool and dry place away from sunlight

What if I have taken an overdose of Cogni-Plus 250mg Injection 2 ml

Cogni-Plus 250mg Injection 2 ml is administered by a health care professional in a hospital setting. Hence, the chances of overdose are less. Overdose may cause severe headache. Your doctor may take necessary measures if an overdose is suspected.

Drug Warnings

Let your doctor know if you are allergic or hypersensitive to any medicines. Inform your doctor if you are suffering from kidney, liver, or heart diseases. Cogni-Plus 250mg Injection 2 ml should not be used in conjunction with meclofenoxate or clophenoxate-containing medications. Notify your doctor about your medical history and medications in order to rule out any potential negative effects.

Drug-Drug Interactions

verifiedApollotooltip
No Drug - Drug interactions found in our data. We may lack specific data on this medicine and are actively working to update our database. Consult your doctor for personalized advice

Drug-Drug Interactions

Login/Sign Up

Drug-Food Interactions

verifiedApollotooltip
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.

Drug-Food Interactions

Login/Sign Up

Diet & Lifestyle Advise

  • Include green, leafy vegetables and other non-starchy vegetables (tomatoes, broccoli, cauliflower, etc.) in your diet.
  • Strawberries, blueberries, blackberries, and nuts may help reduce inflammation in the brain. 
  • Use olive oil for cooking purposes. It contains healthy fats that promote brain health.  
  • Eat whole grains such as oats, quinoa, and brown rice that are rich in nutrients. 
  • Opt for fish oil or eat fish (preferably fatty fish like salmon, sardines, trout, and tuna) at least once a week. They are rich in omega-3 fatty acids essential for the brain's normal functioning. 
  • Avoid fried, processed, and packed foods. 
  • Quit alcohol intake and smoking.
  • Exercise regularly. 

Habit Forming

No

Therapeutic Class

PSYCHOSTIMULANTS

Cogni-Plus 250mg Injection 2 ml Substitute

Substitutes safety advice
  • Strocit Injection 4 ml

    by Others

    69.75per tablet
  • Citiverlin 250mg Injection

    by Others

    57.15per tablet
  • Citcard 250mg Injection

    by Others

    53.39per tablet
  • Citilice 250mg Injection

    by Others

    54.00per tablet
  • Citigold 250mg Injection

    by Others

    136.80per tablet
bannner image

Alcohol

Caution

Avoiding alcohol is recommended to rule out any possibility of side effects.

bannner image

Pregnancy

Caution

There are no adequate and well-controlled studies on pregnant women. Please consult your doctor. Your doctor will prescribe only if the benefits outweigh the risks.

bannner image

Breast Feeding

Caution

There are no adequate and well-controlled studies on nursing mothers. Please consult your doctor. Your doctor will prescribe only if the benefits outweigh the risks.

bannner image

Driving

Caution

Cogni-Plus 250mg Injection 2 ml may cause irregular body movement and double vision; thus, avoid using machinery or driving.

bannner image

Liver

Caution

Let your doctor know if you have a history of liver impairment/disorder. Your doctor will prescribe only if the benefits outweigh the risks.

bannner image

Kidney

Caution

Let your doctor know if you have had a history of kidney impairment/disorder. In aged patients with impaired renal function, the dose should be adjusted.

bannner image

Children

Caution

Limited information is available. Please consult your doctor.

Have a query?

FAQs

Cogni-Plus 250mg Injection 2 ml belongs to a group of medications called 'psychostimulants' used to treat disturbances of consciousness resulting from head injuries, brain operation and acute stage of cerebral infarction (stroke) in adults.

Cogni-Plus 250mg Injection 2 ml It stabilises cell membranes by increasing the production of phosphatidylcholine and sphingomyelin and decreasing the release of free fatty acids; as a result, it helps speed up recovery in patients who have had surgery for head injuries or other brain-related conditions.

Cogni-Plus 250mg Injection 2 ml can cause insomnia (sleeplessness). However, not everybody taking Cogni-Plus 250mg Injection 2 ml experiences this side-effect. If the condition persists or worsens, consult a doctor.

Cogni-Plus 250mg Injection 2 ml must not be administered to patients with hypertonic of the parasympathetic (over-functioning of the sympathetic nervous system) or a history of hypersensitivity to Citicoline.

Country of origin

India

Manufacturer/Marketer address

Unison Pharmaceuticals Pvt. Ltd., Unison House Near Prernatirth Derasar, Near Ratnadeep-Ii, Satellite, Jodhpur, Ahmedabad-380 015, Gujarat, India.
Other Info - COG0101

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
icon image

Keep Refrigerated. Do not freeze.

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

whatsapp Floating Button
Buy Now
Add to Cart